Cargando…

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio help identify patients with lung cancer, but do not differentiate between lung cancer subtypes

AIM: To assess the diagnostic value of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in lung cancer (LC). We compared the ratios between healthy participants and all LC patients, as well patients with different pathohistological LC subtypes. METHODS: We retrieved the da...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nikolić, Igor, Kukulj, Suzana, Samaržija, Miroslav, Jeleč, Vjekoslav, Žarak, Marko, Orehovec, Biserka, Taradi, Ida, Romić, Dominik, Kolak, Toni, Patrlj, Leonardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Croatian Medical Schools 2016
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937224/ https://www.ncbi.nlm.nih.gov/pubmed/27374830 http://dx.doi.org/10.3325/cmj.2016.57.287

Ejemplares similares

Neutrophil-to-lymphocyte Ratio can Predict Outcome in Extensive-stage Small Cell Lung Cancer
por: Drpa, Gordana, et al.
Publicado: (2020)

Efficacy and safety of nintedanib and docetaxel in patients with previously treated lung non-squamous non-small cell lung cancer: a multicenter retrospective real-world analysis
por: Ljubicic, Lidija, et al.
Publicado: (2023)

Trends in lung cancer incidence and mortality in Croatia, 1988 to 2008
por: Janković, Mateja, et al.
Publicado: (2012)

Trends in incidence of lung cancer in Croatia from 2001 to 2013: gender and regional differences
por: Siroglavić, Katarina-Josipa, et al.
Publicado: (2017)

The Interplay of Lung Cancer, COVID-19, and Vaccines
por: Trivanović, Dragan, et al.
Publicado: (2022)

Aiolos and Lymphocyte Mimicry in Lung Cancer
por: Terada, Lance S, et al.
Publicado: (2014)

The prognostic value of neutrophil to lymphocyte and platelet to lymphocyte ratios for patients with lung cancer
por: Wang, Liqun, et al.
Publicado: (2017)

Helping lymphocytes to move on
por: Bashyam, Hema
Publicado: (2008)

Depression in association with neutrophil-to-lymphocyte, platelet-to-lymphocyte, and advanced lung cancer inflammation index biomarkers predicting lung cancer survival
por: Andersen, Barbara L., et al.
Publicado: (2023)

Short Survey on the Protein Modifications in Plasma during SARS-CoV-2 Infection
por: Gęgotek, Agnieszka, et al.
Publicado: (2023)

T lymphocyte cell: A pivotal player in lung cancer
por: Wu, Yanan, et al.
Publicado: (2023)

Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management
por: Šutić, Maja, et al.
Publicado: (2021)

The influence of anti-cancer therapies on lymphocyte subpopulations of lung cancer patients
por: Gessner, Philipp, et al.
Publicado: (2023)

Prognostic significance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in non-small cell lung cancer
por: Bayraktaroglu, Mesut, et al.
Publicado: (2023)

Engineered T lymphocytes eliminate lung metastases in models of pancreatic cancer
por: Sun, Qiang, et al.
Publicado: (2018)

Lymphocyte percentage as a valuable predictor of prognosis in lung cancer
por: Huang, Hong, et al.
Publicado: (2022)

Corrigendum: T lymphocyte cell: A pivotal player in lung cancer
por: Wu, Yanan, et al.
Publicado: (2023)

Total lymphocyte count, neutrophil–lymphocyte ratio, and platelet–lymphocyte ratio as prognostic factors in advanced non–small cell lung cancer with chemoradiotherapy
por: Song, Xinyu, et al.
Publicado: (2018)

Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Blood to Distinguish Lung Cancer Patients from Healthy Subjects
por: Zhu, Xuming, et al.
Publicado: (2020)

The clinical relevance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in chronic obstructive pulmonary disease with lung cancer
por: Ma, Aiping, et al.
Publicado: (2022)

T lymphocyte subsets and PD-1 expression on lymphocytes in peripheral blood of patients with non-small cell lung cancer
por: Chen, Tingting, et al.
Publicado: (2022)

Significance of the Lung Immune Prognostic Index for Assessment of the Reliability of the Clinical Treatment Outcome for Advanced Non-Small-Cell Lung Cancer in Patients with COVID-19 Infection
por: Krpina, Kristina, et al.
Publicado: (2022)

Total Lymphocyte Count, Neutrophil-Lymphocyte Ratio, and Platelet-Lymphocyte Ratio as Prognostic Factors in Advanced Non-Small Cell Lung Cancer with Chemoradiotherapy [Corrigenudm]
Publicado: (2021)

Lymphocytic Airway Inflammation in Lung Allografts
por: Santos, Jesse, et al.
Publicado: (2022)

Prognostic Value of the Neutrophil to Lymphocyte Ratio (NLR) in Lung Cancer Cases
por: Ozyurek, Berna Akinci, et al.
Publicado: (2017)

Neutrophil to Lymphocyte Ratio in Lung Cancer: Implications for Depressive Symptoms and Survival
por: McFarland, Daniel C.
Publicado: (2020)

Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
por: Deng, Min, et al.
Publicado: (2017)

The Prognostic Significance of Preoperative Platelet-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratios in Patients Operated for Non-Small Cell Lung Cancer
por: Łochowski, Mariusz, et al.
Publicado: (2021)

Predictive value of the hemoglobin, albumin, lymphocyte, and platelet (HALP) score and lymphocyte-to-monocyte ratio (LMR) in patients with non-small cell lung cancer after radical lung cancer surgery
por: Zhai, Baoqian, et al.
Publicado: (2021)

Progressive changes in composition of lymphocytes in lung tissues from patients with non-small-cell lung cancer
por: del Mar Valenzuela-Membrives, María, et al.
Publicado: (2016)

The Position of Neutrophils-To-Lymphocytes and Lymphocytes-To-Platelets Ratio as Predictive Markers of Progression and Prognosis in Patients with Non-Small Cell Lung Cancer
por: Minkov, Plamen, et al.
Publicado: (2018)

Early variations in lymphocytes and T lymphocyte subsets are associated with radiation pneumonitis in lung cancer patients and experimental mice received thoracic irradiation
por: Zhou, Pu, et al.
Publicado: (2020)

Prognostic utility of inflammation-based biomarkers, neutrophil–lymphocyte ratio and change in neutrophil–lymphocyte ratio, in surgically resected lung cancers
por: Thompson, Daniel, et al.
Publicado: (2021)

Platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios are associated with the efficacy of immunotherapy in stage III/IV non-small cell lung cancer
por: Lu, Xiaojuan, et al.
Publicado: (2022)

The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer
por: Kang, M H, et al.
Publicado: (2014)

Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysis
por: Yin, Yongmei, et al.
Publicado: (2015)

The role of B lymphocytes in the immuno-biology of non-small-cell lung cancer
por: Patel, Akshay J., et al.
Publicado: (2020)

Immune Effect of T Lymphocytes Infiltrated by Tumors on Non-Small-Cell Lung Cancer
por: Sheng, Siyuan, et al.
Publicado: (2022)

Real-World Safety and Efficacy of Nivolumab in Advanced Squamous and Nonsquamous Non-Small-Cell Lung Cancer: A Retrospective Cohort Study in Croatia, Hungary, and Malta
por: Vrdoljak, Eduard, et al.
Publicado: (2020)

Preoperative lymphocyte-to-monocyte ratio versus platelet-to-lymphocyte ratio as a prognostic predictor for non-small cell lung cancer patients
por: Yan, Haixi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oacmk2uhl58tfr4nplljjsgt46